{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T23:09:15Z","timestamp":1779318555275,"version":"3.51.4"},"reference-count":28,"publisher":"Georg Thieme Verlag KG","issue":"CP","license":[{"start":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T00:00:00Z","timestamp":1778025600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005928","name":"Daiwa Securities Health Foundation","doi-asserted-by":"crossref","award":["52nd Research Grant, No. 20"],"award-info":[{"award-number":["52nd Research Grant, No. 20"]}],"id":[{"id":"10.13039\/501100005928","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["TH Open"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Although the incidence of thromboembolic events after catheter ablation for atrial fibrillation (AF) is low, the residual risk persists. The nature of these long-term events remains poorly characterized, and optimal risk stratification is challenging. We therefore aimed to characterize the postablation ischemic events and develop an enhanced risk stratification model.<\/jats:p>\n                  <jats:p>This single-center historical cohort study enrolled 1,163 patients who underwent initial AF ablation. The primary endpoint was a composite of postdischarge ischemic events (ischemic stroke, transient ischemic attack, and systemic arterial thromboembolism [SE]). The predictability of clinically available risk scores and individual parameters, including left atrial volume index (LAVI), was assessed. The new model combining the strongest predictors was benchmarked against the risk score alone.<\/jats:p>\n                  <jats:p>Over a median follow-up of 5.1 (interquartile range: 3.1\u20137.1) years, 24 patients (2.1%) experienced an ischemic event (incidence: 0.38 per 100 person-years [95% confidence interval, 0.24\u20130.57]). AF-related etiologies (cardioembolic stroke\/SE) accounted for 42% of events. More than half of the events (54%) occurred when the patients were in sinus rhythm. CHA2DS2-VASc score and LAVI were the strongest predictors. A combined model incorporating both parameters showed numerically higher discrimination and modest improvement in reclassification (net reclassification improvement: 0.698 [0.300\u20131.095], p\u2009&lt;\u20090.001) and discrimination (integrated discrimination improvement: 0.009 [0.002\u20130.017], p\u2009=\u20090.014) compared with the CHA2DS2-VASc score alone.<\/jats:p>\n                  <jats:p>In this long-term analysis, postablation ischemic events were infrequent and of mixed etiology, with noncardioembolic causes being common. A combined model integrating CHA2DS2-VASc and LAVI showed modest incremental value for residual risk stratification.<\/jats:p>","DOI":"10.1055\/a-2862-0521","type":"journal-article","created":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T22:44:53Z","timestamp":1778107493000},"source":"Crossref","is-referenced-by-count":0,"special_numbering":"S","title":["Characterisation and Enhanced Residual Risk Stratification of Long-Term Post-Discharge Ischaemic Events After Atrial Fibrillation Catheter Ablation"],"prefix":"10.1055","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4597-7862","authenticated-orcid":false,"given":"Hironori","family":"Ishiguchi","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Yamaguchi University School of Medicine Graduate School of Medicine, Japan","department":["Department of Medicine and Clinical Science"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shintaro","family":"Hashimoto","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Yamaguchi University School of Medicine Graduate School of Medicine, Japan","department":["Department of Medicine and Clinical Science"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhiro","family":"Yoshiga","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Yamaguchi University School of Medicine Graduate School of Medicine, Japan","department":["Department of Medicine and Clinical Science"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masakazu","family":"Fukuda","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Yamaguchi University School of Medicine Graduate School of Medicine, Japan","department":["Department of Medicine and Clinical Science"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Goki","family":"Nakashima","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Yamaguchi University School of Medicine Graduate School of Medicine, Japan","department":["Department of Medicine and Clinical Science"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuya","family":"Omuro","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Yamaguchi University School of Medicine Graduate School of Medicine, Japan","department":["Department of Medicine and Clinical Science"]},{"name":"Yamaguchi University Wellness Science Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noriko","family":"Fukue","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Yamaguchi University School of Medicine Graduate School of Medicine, Japan","department":["Department of Medicine and Clinical Science"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeki","family":"Kobayashi","sequence":"additional","affiliation":[{"name":"Yamaguchi University School of Medicine, Japan","department":["Department of Therapeutic Science for Heart Failure in the Elderly"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Motoaki","family":"Sano","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Yamaguchi University School of Medicine Graduate School of Medicine, Japan","department":["Department of Medicine and Clinical Science"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"194","published-online":{"date-parts":[[2026,5,6]]},"reference":[{"issue":"09","key":"ref1","doi-asserted-by":"crossref","first-page":"euad226","DOI":"10.1093\/europace\/euad226","article-title":"Atrial fibrillation and stroke prevention: 25 years of research at EP Europace journal","volume":"25","author":"G YH Lip","year":"2023","journal-title":"Europace"},{"issue":"36","key":"ref2","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1093\/eurheartj\/ehae176","article-title":"2024 ESC guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)","volume":"45","author":"I C Van Gelder","year":"2024","journal-title":"Eur Heart J"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"100797","DOI":"10.1016\/j.lanepe.2023.100797","article-title":"Atrial fibrillation: stroke prevention","volume":"37","author":"T-F Chao","year":"2024","journal-title":"Lancet Reg Health Eur"},{"issue":"03","key":"ref4","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.jacep.2024.10.029","article-title":"Temporal trends of ischemic stroke risk in patients with incident atrial fibrillation before anticoagulation","volume":"11","author":"K Teppo","year":"2025","journal-title":"JACC Clin Electrophysiol"},{"issue":"09","key":"ref5","first-page":"e011861","article-title":"Temporal trends and lesion sets for persistent atrial fibrillation ablation: a meta-analysis with trial sequential analysis and meta-regression","volume":"16","author":"A Sau","year":"2023","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"04","key":"ref6","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1056\/NEJMoa2029554","article-title":"Cryoballoon ablation as initial therapy for atrial fibrillation","volume":"384","author":"O M Wazni","year":"2021","journal-title":"N Engl J Med"},{"issue":"04","key":"ref7","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1056\/NEJMoa2029980","article-title":"Cryoablation or drug therapy for initial treatment of atrial fibrillation","volume":"384","author":"J G Andrade","year":"2021","journal-title":"N Engl J Med"},{"issue":"01","key":"ref8","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.hrthm.2025.05.021","article-title":"Ablation of atrial fibrillation and risk of stroke: a meta-analysis","volume":"23","author":"R Providencia","year":"2026","journal-title":"Heart Rhythm"},{"issue":"10","key":"ref9","doi-asserted-by":"crossref","first-page":"2970","DOI":"10.1161\/STROKEAHA.119.026890","article-title":"Atrial fibrillation ablation and reduction of stroke events: understanding the paradoxical lack of evidence","volume":"50","author":"S Barra","year":"2019","journal-title":"Stroke"},{"issue":"07","key":"ref10","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1253\/circj.CJ-20-0637","article-title":"JCS\/JHRS 2019 guideline on non-pharmacotherapy of cardiac arrhythmias","volume":"85","author":"A Nogami","year":"2021","journal-title":"Circ J"},{"issue":"01","key":"ref11","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jacc.2023.08.017","article-title":"2023 ACC\/AHA\/ACCP\/HRS guideline for the diagnosis and management of atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Joint Committee on clinical practice guidelines","volume":"83","author":"J A Joglar","year":"2024","journal-title":"J Am Coll Cardiol"},{"issue":"07","key":"ref12","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1093\/eurheartj\/ehad874","article-title":"Interruption of oral anticoagulants after atrial fibrillation catheter ablation: the importance of risk stratification","volume":"45","author":"S Brienesse","year":"2024","journal-title":"Eur Heart J"},{"issue":"07","key":"ref13","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1093\/eurheartj\/ehad798","article-title":"Oral anticoagulation after atrial fibrillation catheter ablation: benefits and risks","volume":"45","author":"K Kanaoka","year":"2024","journal-title":"Eur Heart J"},{"issue":"03","key":"ref14","doi-asserted-by":"crossref","first-page":"e251320","DOI":"10.1001\/jamanetworkopen.2025.1320","article-title":"Discontinuation of oral anticoagulation after successful atrial fibrillation ablation","volume":"8","author":"T Iwawaki","year":"2025","journal-title":"JAMA Netw Open"},{"issue":"31","key":"ref15","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1093\/eurheartj\/ehw087","article-title":"Catheter ablation for atrial fibrillation is associated with lower incidence of stroke and death: data from Swedish health registries","volume":"37","author":"L Friberg","year":"2016","journal-title":"Eur Heart J"},{"key":"ref16","first-page":"107","article-title":"Stroke rates before and after ablation of atrial fibrillation and in propensity-matched controls in the UK","volume":"8","author":"J W Jarman","year":"2017","journal-title":"Pragmat Obs Res"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"102181","DOI":"10.1016\/j.cpcardiol.2023.102181","article-title":"Atrial fibrillation and stroke: State-of-the-art and future directions","volume":"49","author":"S Elsheikh","year":"2024","journal-title":"Curr Probl Cardiol"},{"issue":"11","key":"ref18","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/j.jacc.2024.11.052","article-title":"Biomarker-based model for prediction of ischemic stroke in patients with atrial fibrillation","volume":"85","author":"L Wallentin","year":"2025","journal-title":"J Am Coll Cardiol"},{"issue":"04","key":"ref19","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.jclinepi.2007.11.008","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"61","author":"E von Elm","year":"2008","journal-title":"J Clin Epidemiol"},{"issue":"01","key":"ref20","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1161\/01.STR.24.1.35","article-title":"Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment","volume":"24","author":"H P Adams Jr","year":"1993","journal-title":"Stroke"},{"issue":"07","key":"ref21","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1253\/circj.CJ-24-0073","article-title":"JCS\/JHRS 2024 guideline focused update on management of cardiac arrhythmias","volume":"89","author":"Y K Iwasaki","year":"2025","journal-title":"Circ J"},{"issue":"04","key":"ref22","doi-asserted-by":"crossref","first-page":"e023640","DOI":"10.1161\/JAHA.121.023640","article-title":"Impact of atrial tachyarrhythmia recurrence on the development of long-term adverse clinical events following catheter ablation in patients with atrial fibrillation with systolic impairment: a single-center observational study","volume":"11","author":"H Ishiguchi","year":"2022","journal-title":"J Am Heart Assoc"},{"issue":"08","key":"ref23","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1161\/STROKEAHA.119.025350","article-title":"Causes and risk factors of cerebral ischemic events in patients with atrial fibrillation treated with non-vitamin K antagonist oral anticoagulants for stroke prevention","volume":"50","author":"M Paciaroni","year":"2019","journal-title":"Stroke"},{"issue":"02","key":"ref24","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1177\/23969873231168367","article-title":"The contribution of competing mechanisms in stroke despite anticoagulation in patients with atrial fibrillation","volume":"8","author":"R Herlekar","year":"2023","journal-title":"Eur Stroke J"},{"issue":"10","key":"ref25","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1016\/j.hrthm.2025.05.067","article-title":"Stroke risks in women vs men in Asian patients with atrial fibrillation: a temporal trend analysis and a comparison of the CHA2DS2-VASc and CHA2DS2-VA stroke risk stratification scores","volume":"22","author":"W-H Cheng","year":"2025","journal-title":"Heart Rhythm"},{"issue":"05","key":"ref26","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1093\/ehjcvp\/pvaf031","article-title":"Stroke risk stratifications according to CHA2DS2-VASc vs. CHA2DS2-VA in patients with atrial fibrillation: insights from the GLORIA-AF registry","volume":"11","author":"S HM Lam","year":"2025","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"issue":"08","key":"ref27","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1093\/ehjqcco\/qcaf075","article-title":"Atrial fibrillation and female sex: use of oral anticoagulants in a large European cohort and residual risk of thromboembolism and stroke","volume":"11","author":"D A Mei","year":"2025","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"issue":"04","key":"ref28","doi-asserted-by":"crossref","first-page":"e202881","DOI":"10.1001\/jamanetworkopen.2020.2881","article-title":"Risk factors associated with ischemic stroke in Japanese patients with nonvalvular atrial fibrillation","volume":"3","author":"K Okumura","year":"2020","journal-title":"JAMA Netw Open"}],"container-title":["TH Open"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-2862-0521.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T22:52:58Z","timestamp":1779317578000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-2862-0521"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,6]]},"references-count":28,"journal-issue":{"issue":"CP","published-online":{"date-parts":[[2026,1,9]]},"published-print":{"date-parts":[[2026]]}},"alternative-id":["a28620521"],"URL":"https:\/\/doi.org\/10.1055\/a-2862-0521","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["2512-9465"],"issn-type":[{"value":"2512-9465","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,6]]}}}